Michael Roger Harrison, MD

Assistant Professor of Medicine
Member of the Duke Cancer Institute
Email address michael.harrison@duke.edu

Education and Training

  • Residency, Medicine, Tulane University, 2004 - 2007
  • M.D., Tulane University, 2004

Publications

Gopalakrishna, A, Longo, TA, Fantony, JJ, Harrison, MR, and Inman, BA. "Physical activity patterns and associations with health-related quality of life in bladder cancer survivors." Urologic oncology 35, no. 9 (September 2017): 540.e1-540.e6.

PMID
28527621
Full Text

Ramalingam, S, Humeniuk, MS, Hu, R, Rasmussen, J, Healy, P, Wu, Y, Harrison, MR, Armstrong, AJ, George, DJ, and Zhang, T. "Prostate-specific antigen response in black and white patients treated with abiraterone acetate for metastatic castrate-resistant prostate cancer." Urologic oncology 35, no. 6 (June 2017): 418-424.

PMID
28126272
Full Text

Motzer, RJ, Jonasch, E, Agarwal, N, Bhayani, S, Bro, WP, Chang, SS, Choueiri, TK, Costello, BA, Derweesh, IH, Fishman, M, Gallagher, TH, Gore, JL, Hancock, SL, Harrison, MR, Kim, W, Kyriakopoulos, C, LaGrange, C, Lam, ET, Lau, C, Michaelson, MD, Olencki, T, Pierorazio, PM, Plimack, ER, Redman, BG, Shuch, B, Somer, B, Sonpavde, G, Sosman, J, Dwyer, M, and Kumar, R. "Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology." Journal of the National Comprehensive Cancer Network : JNCCN 15, no. 6 (June 2017): 804-834.

PMID
28596261
Full Text

Bhavsar, NA, Harrison, MR, Hirsch, BR, Creel, P, Wolf, SP, Samsa, GP, Abernethy, AP, Simantov, R, Borham, A, and George, DJ. "Design and Rationale of the Metastatic Renal Cell Carcinoma (MaRCC) Registry: A Prospective Academic and Community-Based Study of Patients With Metastatic Renal Cell Cancer." Cancer investigation 35, no. 5 (May 2017): 333-344.

PMID
28368708
Full Text

Madden-Fuentes, RJ, Koontz, BF, Harrison, MR, George, DJ, Davidson, B, Gilmore, BF, Moul, JW, Mantyh, C, and Peterson, AC. "How can we effectively address the medical and psychological concerns of survivors of pelvic malignancies?." ONCOLOGY (United States) 31, no. 4 (April 15, 2017): 268-294. (Review)

Scholars@Duke

Inman, BA, Longo, TA, Ramalingam, S, and Harrison, MR. "Atezolizumab: A PD-L1-Blocking Antibody for Bladder Cancer." Clinical cancer research : an official journal of the American Association for Cancer Research 23, no. 8 (April 2017): 1886-1890. (Review)

PMID
27903674
Full Text

Madden-Fuentes, RJ, Koontz, BF, Harrison, MR, George, DJ, Davidson, B, Gilmore, BF, Moul, JW, Mantyh, C, and Peterson, AC. "How Can We Effectively Address the Medical and Psychological Concerns of Survivors of Pelvic Malignancies?." Oncology (Williston Park, N.Y.) 31, no. 4 (April 2017): 286-294. (Review)

PMID
28412780
Scholars@Duke

Armstrong, AJ, Humeniuk, MS, Healy, P, Szmulewitz, R, Winters, C, Kephart, J, Harrison, MR, Martinez, E, Mundy, K, Halabi, S, and George, D. "Phase Ib Trial of Cabazitaxel and Tasquinimod in Men With Heavily Pretreated Metastatic Castration Resistant Prostate Cancer (mCRPC): The CATCH Trial." PROSTATE 77, no. 4 (March 1, 2017): 385-395.

Full Text

Armstrong, AJ, Humeniuk, MS, Healy, P, Szmulewitz, R, Winters, C, Kephart, J, Harrison, MR, Martinez, E, Mundy, K, Halabi, S, and George, D. "Phase Ib Trial of Cabazitaxel and Tasquinimod in Men With Heavily Pretreated Metastatic Castration Resistant Prostate Cancer (mCRPC): The CATCH Trial." March 2017.

PMID
27862097
Full Text

Ramalingam, S, Eisenberg, A, Foo, WC, Freedman, J, Armstrong, AJ, Moss, LG, and Harrison, MR. "Treatment-related neuroendocrine prostate cancer resulting in Cushing's syndrome." International journal of urology : official journal of the Japanese Urological Association 23, no. 12 (December 2016): 1038-1041.

PMID
27766686
Full Text

Pages